Ocular Therapeutix (OCUL) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Ocular Therapeutix (OCUL) is Neutral.

The composite score behind that read is -0.18, weighing +0.07 of bullish evidence against -0.37 bearish.

Ocular Therapeutix last closed at $7.54, +0.40% on the session.

Against the IVW growth benchmark the position is -0.40% over the forecast window.

The read is built from 15 underlying insights — 1 bullish and 14 bearish.

Agreement across those insights is 93%.

20 graded predictions for OCUL so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Ocular Therapeutix in the 16th percentile on return on equity, where 100 is best.

Ocular Therapeutix is classified under Health Care / Pharmaceuticals, with a market capitalisation of $1.65B.

StockMap tracks Ocular Therapeutix as the 48th largest of the 151 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 90 Neutral, 46 Moderate Underperform and 15 Moderate Outperform.

On that composite Ocular Therapeutix ranks 101st of 151 in the group, against a group median of -0.08.